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Abstract – Introduction. Endocrine disorders have influence on 
the functioning of almost the whole body. Thyroid diseases affect 
2-5% of society, more often in women and the elderly.  
The aim of the study. The aim of the study was to present an 
impact of thyroid diseases on temporomanidbular disorders 
(TMD). 
Materials and methods. : Research material was a retrospective 
medical records of 322 patients aged (40,2 ±10,6 years)  with the  
Questionnaires of Manual Functional Analysis of masticatory 
system (MFA) due to DC/TMD of patients with TMD, who un-
derwent physiotherapy for TMD  in Dentists Clinic in Kraków, 
from November 2017 to April 2018. Fourty four (40,2 ±10,6 
years) patients with TMD and co-occurring thyroid diseases was 
isolated and divided according to the diagnosis of thyroid disease 
into four groups: hypothyroidism (N1=13), hyperthyroidism 
(N2=11), Hashimoto’s disease (N3=11) thyroid nodules (N4=9). A 
questionnaire of Manual Functional Analysis of masticatory sys-
tem (MFA) and a questionnaire for palpation of head and neck 
muscles according to Festa were used. Statistical processing of 
the data was conducted considering significance at a p-value < 
0.05. 
Results. Study presents that hypomobility of temporomandibular 
joints (TMJ) was typical for patients with hypothyroidism 
(84,6%), and hypermobility of TMJ was more frequent in patients 
with hyperthyroidism (45,5%). Patients with Hashimoto's disease 
were often diagnosed with pain syndromes of masticatory system 
(90,9%). Tension headaches (58,8%) and tinnitus (52,3%) coex-
isted with TMJ disorders in thyroid diseases. However, no signif-
icant differences were found between group of thyroid diseases 
(p>0.05).  
Conclusions. Thyroid diseases have some influence on signs and 
symptoms of TMD. However, there were no statistically signifi-
cant differences between the types of thyroid diseases and the 
symptoms of TMD.  
 
Key words – thyroid diseases, temporomandibular disorders 
(TMD), temporomandibular joints (TMJ), masticatory motor 
system. 
  
 
 
 
 
Streszczenie – Wprowadzenie. Zaburzenia endokrynologiczne 
mają wpływ na funkcjonowanie niemalże całego organizmu. 
Choroby tarczycy dotyczą 2-5% społeczeństwa, częściej 
występują u kobiet i w wieku starszym.  
Cel badań. Ukazanie wpływu chorób tarczycy na objawy dys-
funkcji układu ruchowego narządu żucia (URNŻ). 
Materiał i metodyka. Badania retrospektywne przeprowadzono na 
podstawie analizy 322 kart badań pacjentów Manualnej Funkc-
jonalnej Analizy URNŻ (MFA) w oparciu o kryteria DC/TMD, 
którzy poddali się fizjoterapii Stomatognatycznej na terenie Klin-
ik Stomatologicznych w Krakowie. Grupę 44 pacjentów (40,2 
±10,6 lat) z zaburzeniami URNŻ i współwystępującymi 
chorobami tarczycy, podzielono na cztery podgrupy: 
niedoczynność tarczycy (N1=13), nadczynność tarczycy (N2=11), 
choroba Hashimoto (N3=11), guzki tarczycy (N4=9). Zastosowa-
no kwestionariusz Manualnej Funkcjonalnej Analizy URNŻ 
(MFA) oraz kwestionariusz badania palpacyjnego mięśni głowy i 
szyi wg Festy. Dane zostały poddane analizie statystycznej z 
uwzględnieniem wskaźnika p-value <0.05.  
Wyniki. Zaobserwowano, że objawy hypomobilności SSŻ 
występowały u pacjentów z niedoczynnością tarczycy (84,6%), a 
hypermobilność była częstsza u chorych z nadczynnością tar-
czycy (45,5%). U pacjentów z chorobą Hashimoto najczęściej 
diagnozowano zespoły bólowe URNŻ (90,9%). Napięciowe bóle 
głowy (58,8%) oraz szumy uszne (52,3%) współwystępowały z 
zaburzeniami URNŻ w chorobach tarczycy. Jednakże nie zau-
ważono dominacji powyższych objawów w poszczególnych 
chorobach tarczycy (p>0.05). 
Wnioski. Choroby tarczycy mają wpływ na objawy bezpośrednie 
i pośrednie dysfunkcji URNŻ. Aczkolwiek nie wykazano stat-
ystycznie istotnych różnic pomiędzy rodzajami chorób tarczycy a 
objawami dysfunkcji URNŻ.  
 
Słowa kluczowe – choroby tarczycy, dysfunkcje stawów skronio-
wo-żuchwowych, układ ruchowy narządu żucia. 
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I. INTRODUCTION 
 
ue to the thyroid hormone production capacity, we 
distinguish endocrine disorders in the following areas: 
hypothyroidism and overactive thyroid gland [1]. An 
underactive thyroid (hypothyroidism) is a set of clinical 
symptoms that results from a deficiency of thyroid hor-
mones in the blood, which in turn leads to disorders of the 
tissues and organs of the body [2]. In contrast, hyperthy-
roidism is a set of symptoms, caused by excessive produc-
tion of thyroid hormones triiodothyronine (T3) and thyrox-
ine (T4), leading to the occurrence of metabolic disorders 
and the activities of internal organs [3].  
The population of thyroid disease relates to 2-5% of the 
population. The frequency of their occurrence increases 
with age and after the age of 75 is approx. 15% [4]. In Po-
land, hypothyroidism affects 4-10% of society [5]. Women 
are more often affected by hypothyroidism (80% of pa-
tients) [2], mainly older people over 60 years old [1]. 
Overactive thyroid concerns in the general population of 
1,2% people [6]. Hyperthyroidism is five times more 
common in women than in men. One of the most common 
forms is Graves' disease (about 75% of hyperthyroidism) 
[7]. Hyperthyroidism affects the white race more than the 
black race, ten times more often [8]. 
 Symptoms of thyroid gland diseases, especially in the 
early stages of the disease, are nonspecific (Table 1.). Thy-
roid hormones also affect the movement system. They 
have an essential influence on bone formation, growth, and 
remodeling, concerning the four central cells of bone tissue 
– osteocytes, osteoblasts, osteoclasts and chondrocytes [10, 
11, 12]. In underactivity, bone formation processes are 
reduced by 50% and its resorption in 40% [13].  
Table 1. The main symptoms of hypothyroidism and hy-
perthyroidism 
 
Hypothyroidism Hyperthyroidism 
fatigue, loss of physical performance, 
drowsiness 
hyperactivity, insomnia, nervousness 
decrease in peristalsis 
constipation, bloating 
increase in intestinal peristalsis 
frequent bowel movements, diarrhea 
bradypnea dyspnea, tachypnea 
reduced cardiac output 
heart enlargement 
bradycardia 
coronary pain 
arrhythmias, including atrial fibrillation 
tachycardia 
the decrease in diastolic blood pressure 
concentration and memory disorders 
greater tendency to depression 
paresthesia 
Cretinism thyroid (children) 
concentration disorders 
nervousness, crying 
shaking hands 
increase in neuromuscular excitability 
menstrual disorders 
infertility 
menstrual disorders 
infertility 
dryness and pale skin 
cold intolerance 
swelling of the face and eyelids, thick-
ening of the tongue, hair loss 
nail fragility 
warm, smooth, moist skin, dermatog-
raphy 
itchiness 
exophthalmos and swelling of orbital 
tissue 
hair loss 
nail fragility 
weight gain weight loss 
 
Extending the bone growth time makes it challenging to 
remineralize the bone and maintain healthy bone mass 
[10]. Thyroid hypothyroidism is thought to contribute to a 
2-3x increase in the risk of bone fractures over the next 10 
years [11, 14, 15-18]. In hyperthyroidism, excessive osteo-
clast stimulation occurs, leading to bone demineralization. 
The bone quality and its ability to regenerate deteriorate 
[19, 20]. Osteopenia developing in bone increases the risk 
of fractures and osteoporosis. This risk is defined as 36% 
higher compared to people with normal thyroid hormone 
levels. Hyperthyroidism is one of the modifiable risk fac-
tors for osteoporosis, especially in postmenopausal women 
[19- 21]. Thyroid hormones also affect muscle contractility 
and metabolism. T3 also participates in the embryonic and 
later development of skeletal muscles through the activa-
tion of fibers for growth. The above action manifests itself 
in hypothyroidism as a delayed contraction and relaxation 
of the muscles, and in the case of the overactive thyroid 
gland as excessive shrinkage [22].  
Painless forms of temporomandibular joint dysfunctions 
are the primary hypertonia of masticatory muscle muscles, 
muscle stiffness, asymmetry of their functioning, and par-
aesthesia [23]. Pain forms include pressure soreness and 
the presence of trigger points. 
Also, hypothyroidism is characterized by muscular 
symptoms (Hoffman syndrome) of the nature of myopathy, 
i.e., pain, stiffness, spasms, fatigability, and weakness of 
muscle strength, which affect from 25% to 75% of patients 
[24]. However, in the hyperthyroidism, the symptoms of 
D 
● JOURNAL OF PUBLIC HEALTH, NURSING AND MEDICAL RESCUE ● No.1/2019 ● 
 
23 
 
myopathy, i.e., muscle weakness occurring without the 
growth of creatinine kinase [25], affect 62% of patients 
[24].  
Until now, the literature has focused on linking thyroid 
diseases with osteoporosis [19-21], inflammatory and 
rheumatic diseases [26, 27]. Manifestation of thyroid dis-
eases in the locomotor system suggests that they may in-
fluence the occurrence and dysfunction symptoms of the 
masticatory apparatus. Therefore, the aim of this study was 
to present the influence of thyroid endocrine disorders on 
the direct and indirect dysfunction symptoms of the masti-
catory apparatus. 
1. Are there any changes in the mobility of the mandible 
in diseases of the thyroid coexisting with TNJ disorders? 
2. Is there a relationship between the severity of pain 
and thyroid disease? 
3. Is there a relationship between the occurrence of 
headaches in patients with TNJ dysfunctions and thyroid 
diseases? 
4. Is there a relationship between the occurrence of tin-
nitus in patients with TNJ dysfunction in connection 
with thyroid diseases? 
 
 
II. MATERIALS AND METHODS 
 
 
Material 
 
The study analyzed treatment cards of 322 patients who  
were treated for temporomandibular joint disorders at the 
Vita Medical Dentistry Institute, Dentist Dentistry and the 
Stomatognathic Clinic in Krakow were analyzed. After 
considering the inclusion and exclusion criteria from the 
studies (Figure 1, Table 2), a group of 44 people (14% of 
the respondents) in working age (average age was 40.2 ± 
10.6 years) with symptoms of temporomandibular joint 
dysfunctions and thyroid disease was identified diagnosed 
by an endocrinologist. 
 
 
Figure 1. Division of the test group of patients with masti-
catory organ motor system dysfunction (TMJ) 
 
 
Table 2. The criteria for inclusion and exclusion of studies 
 
Inclusion criteria for the study: 
1. occurrence of TMJ dysfunction 
2. TMJ disorders coexisting with diagnosed thyroid diseases, i.e., hypothy-
roidism, hyperthyroidism, Hashimoto's disease, and thyroid nodules 
3. consent to participate in the study 
Exclusion criteria for the study: 
1. no diagnosis of TMJ dysfunction 
2. no coexistence of thyroid diseases with TMJ dysfunctions or lack of thyroid 
disease diagnosed by an endocrinologist (only suspicion of disorders - no 
treatment implemented) 
rheumatic and inflammatory diseases 
3. facial injuries, head, cervical spine 
4. neuromuscular diseases, 
5. central and peripheral nervous system diseases 
6. post-operative condition within the cervical spine 
7. pregnancy 
8. no consent to participate in the study 
 
Methodology 
 
The results were obtained through a retrospective  
analysis of patients treatment cards, which included a TMJ 
(MFA) Manual Functional Analysis based on the DC / 
TMD criteria [26] and a Festa head and neck palpation 
questionnaire. The study card was filled in by a person 
specialized in stomatognathic physiotherapy and leading a 
patient's therapy. The results of the research were collected 
from November 2017 to April 2018. 
MFA Questionnaire - Manual Functional Analysis TMJ 
consisted of patient's personal data, anamnesis about cur-
rent and past symptoms of temporomandibular joints, 
headaches, tinnitus, diseases (including endocrine thyroid 
diseases) and a physical examination questionnaire, which 
included: assessment of the range of motion of the tempo-
ro-mandibular joints (abduction, protrusion, lateral move-
ments of the mandible). The measurement of mobility was 
made using a millimeter ruler. To determine the mobility 
of the mandible, the extent of its active dehydration was 
determined as the difference of measurement before thera-
py and measurement of individual patient functional norm 
(distance measured between interphalangeal joints further 
in mm). As a criterion qualifying the diagnosis of move-
ment disorders, a difference of results greater than (-) 5 
mm, hypermobility - difference of results above (+) 5 mm, 
proper range of movement - no deviations from functional 
norm was assumed for hypomobility. 
According to Festy, head and neck examination con- 
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sisted in subjective assessment of pain intensity in a 10-
point VAS scale, where: 0 - no pain, 1-3 - feeling of pres-
sure, 4-6 - moderate pain, 7-8 - severe pain, 9-10 - the 
strongest pain possible. The palpation examination was 
carried out according to the protocol in the reference points 
for selected muscles, i.e.: temporal muscle, masseter mus-
cle, sternocleidomastoid muscle and quadrangular muscle, 
which were examined symmetrically. 
Statistical analysis was performed in the STATISTICA 13 
program. The charts were prepared in Microsoft Excel. 
Fisher's exact test was performed to show the relationship 
between individual thyroid diseases and the symptoms of 
TMJ disorders. The significance level α = 0.05 was as-
sumed. 
 
III. RESULTS  
 
In the study group (N = 44) prevailed hypermobility of 
SSŻ and its features, which were found in 65.9% of sub-
jects. Then, in terms of prevalence, SSR was hypermobility 
- 22.7% in total. Only 11.4% of respondents had the cor-
rect range of movement of the mandibular abduction. 
The distribution of the incidence of motion disorders in 
SSV in thyroid diseases indicates a significant dominance 
of hypomobility in all types of dysfunction of the thyroid 
gland (Figure 2).  
 
 
 
Figure 2. Layout of the incidence of motion disorders of 
Temporomandibular Joint Syndrome in thyroid diseases 
 
It was noted that the greatest disproportion of these disor-
ders occurred in the group of patients with hypothyroid-
ism, where in 85% patients occured hypomobility. In con-
trast, hypermobility was most often observed in patients 
with hyperthyroidism (about 46%), but also as often as 
limitation of mobility in this group (about 46% of respond-
ents). Statistical analysis did not show a significant rela-
tionship between the occurrence of motion disorders in the 
mandible in particular types of thyroid diseases (p = 0.38). 
In terms of diagnosing dysfunctions within TMJ, a   
significant dominance of the TMJ pain was noticed, which 
occurred in 70.5% of the subjects. Most often in the case 
of Hashimoto's disease (90.9%), then thyroid nodules 
(77.8%) and subsequently hypothyroidism (69.2%) and 
hyperthyroidism (45.5%). The diagnosis of polyarticular 
laxity related to almost 1/5 of patients, similarly in the case 
of bruxism. The SSV joint instability was found only in 
6.8% of cases. In addition, it was demonstrated that the 
polyarticular laxity was most common in hyperthyroidism 
(45.5%). However, in the group of people with hypothy-
roidism, no case of this dysfunction was demonstrated 
(Figure 3.).  
 
 
 
Figure 3. Layout of the incidence of TMJ dysfunction in 
thyroid disease groups 
 
The examination of patients for myofascial pain showed 
that Hashimoto's disease (over 80%) and hyperthyroidism 
are the most pain-sensitive type of thyroid disease (about 
73%) (Figure 4.).  
 
 
 
Figure 4. Layout of the incidence of fasciotomies pains in 
thyroid diseases 
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However, statistical analysis by Fisher's exact test did not 
show that the occurrence of myofascial pain is dependent 
on the type of thyroid disease (p = 0.29). 
In the study group, the incidence of headache was  
58.8%. In a detailed analysis, it was shown that they had a 
slight advantage in hypothyroidism (61.5%) and subse-
quently in the case of nodules of the thyroid gland (55.6%) 
and Hashimoto's disease (54.5%). The problem of occur-
rence of tinnitus was reported by 52.3% of patients. Both 
in the case of headaches and tinnitus, the dominance of 
these symptoms in individual thyroid diseases has not been 
demonstrated (successively p = 0.97, p = 0.98). 
 
 
IV. DISCUSSION 
 
The assessment of the direct impact of thyroid diseases  
on SSJ has been undertaken by few authors so far. Recent 
reports from Grozdinska et al. have shown that there is a 
risk of developing SSV dysfunction in patients with Hash-
imoto's disease, symptoms of which occurred in all sub-
jects. It was also noticed in the increased painfulness of 
SSŻ (on average by 2.7x higher). Also, more often in these 
patients there was a pain during abduction of the mandible 
and diagnosis of the most painful forms of TMJ [29]. Own 
research also confirms the hypothesis that Hashimoto's 
disease is most often associated with the appearance of 
TMJ pain. Grenga et al. presented a case study of a patient 
with a malocclusion and inflammation of SSJ and Hash-
imoto's disease. The authors showed that only a combina-
tion of treatment of thyroid disorders with TMJ therapy 
allowed to reduce pain and dysfunctions within the SSŻ in 
the patient [30]. 
In the current literature, there are no direct links be 
tween the disabilities of SSŻ and thyroid disorders. Until 
now, the authors have shown the effect of thyroid disorders 
on the mobility of other joints, especially of the brachioral-
scapular joint. Blonna et al. noticed that in the group of 
people with hypothyroidism, 75% developed postoperative 
joint stiffness, so called shoulder frozen. In addition, pa-
tients with hypothyroidism had a much more limited range 
of brachial articular mobility and increased postoperative 
pain, compared to postoperative patients without endocrine 
thyroid disorders [31]. Manske et al. also emphasize that 
the frozen shoulder is usually associated with hypothyroid-
ism [32]. Radu et al., on the other hand, characterized the 
discomforts of the musculoskeletal system in hypotyreose, 
stressing that muscle pain occurred in 83% and limited 
joint mobility in 16.7% of cases [33]. In the on-house re-
search, it was noted that the most common was limitation 
of jaw mobility, while the most cases of this type were 
noted among patients with hypothyroidism. This result 
correlates with the thesis of the authors regarding the limi-
tation of joint mobility in hypotyreose. However, further 
research is needed so that the above results can be included 
in the general population of patients with hypothyroidism. 
Until now, scientists have not dealt with the problem of the 
occurrence of polyarticular laxity and hypermobility in 
hyperthyroidism. In-house research has noticed these con-
nections and forms the basis for wider observation of this 
phenomenon. In the studied group, hypermobility of SSŻ 
was the most frequent among people with hyperthyroidism. 
A large percentage of hypermobility in hyperthyroidism in 
these patients can be explained by the large occurrence of 
polyarticular laxity in this group. It is worth noting that 
there was no case of polyarticular laxity in the hypothy-
roidism in the study group. The above observations are an 
interesting phenomenon that should be examined in more 
patients to obtain binding conclusions. 
Another problem that was raised at work was the rela- 
tionship between the severity of pain in particular thyroid 
diseases. An experimental study in mice Yi et al., showed 
that hypothyroidism is a predisposing factor for nocicep-
tive hypersensitivity, especially in the case of thermal 
stimuli [34]. Similar results were found in the in-house 
study, hypothyroid patients struggled with pain in almost 
70%. Suk found elevated levels of anti-thyroid peroxidase 
antibodies (anti-TPO) in 19% of patients with fibromyalgia 
[27]. In contrast, Bazzichi et al. noticed a connection be-
tween thyroid autoimmunity and an increased risk of de-
veloping fibromyalgia. In addition, they proved that pa-
tients with fibromyalgia and Hashimoto disease have high-
er values in the subjective assessment of VAS pain and are 
more likely to have fatigability compared to patients with 
fibromyalgia alone [27]. The authors also suggest that pa-
tients with Hashimoto's disease have a reduced threshold 
of pain and a significantly prolonged duration of pain 
symptoms [27, 28]. In addition, Corsalini et al. pointed out 
the need to include in the diagnosis of fibromyalgia pain 
located within the SSR, because in 67% of cases in patients 
with fibromyalgia, pain was localized in this area [35]. 
Ahmad et al. noticed that thyroid autoimmune diseases are 
often associated with the occurrence of pain syndromes 
[36]. It was demonstrated that among patients with rheu-
matoid arthritis and Hashimoto's disease as much as 40% 
had been diagnosed with fibromyalgia or chronic pain syn-
drome [37]. Our results confirm the fact that in Hashimo-
to's disease, nociceptive hypersensitivity was the highest, 
and the diagnosis of TMJ pain was most frequent. 
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The fact that hypothyroidism is associated with the         
coexistence of headaches and migraines is known in the 
literature. The International Classification of Headaches 
(ICDH-3 beta) distinguishes headaches occurring with 
hypothyroidism (HAH – Headache attributed to hypothy-
roidism) and reports their incidence at approx. 30% [38]. 
In addition, Lima Carvalho et al. studied patients with 
HAH and episodic, accompanied by nausea and vomiting, 
receding after treatment with levothyroxine [39]. The au-
thors noticed the TTH and chronic migraine [40-42]. At-
tention is also given to the fact that hypothyroidism may be 
predisposing to the occurrence of tension headaches [43- 
45]. In addition, studies have shown more patients with 
migraines than patients with hypothyroidism [44]. The 
results of the observations also lead to the thesis that head-
aches most often occur in hypothyroidism. However, the 
tinnitus problem appeared in almost all cases of thyroid 
disease. Analogous results can be found in the literature on 
thyroid diseases, including the occurrence of deafness and 
tinnitus. However, they are a phenomenon of dominance in 
a given thyroid disease [46] (Corti's auditory cells [47].). 
In turn, Santosh et al. observed the relationship between 
hypotyreosis and Meniere's disease, which is a disfunction 
of the inner ear, manifesting itself with tinnitus. The au-
thors suggest that patients with Meniere's disease should be 
examined for thyroid disease [48]. 
In conclusion, the issue of own research was discussed  
in the literature as separate issues. Attention was drawn to 
the relationship between the occurrence of thyroid diseases 
and symptoms such as movement disorders, feeling of 
pain, occurrence of headaches or tinnitus. However, until 
now, these dependencies in the context of SSŻ disorders 
have not been studied. The combination of these initially 
non-obvious factors will allow for a comprehensive as-
sessment of the patient's condition. In-house research high-
lights the impact of systemic diseases on the human body 
and on the symptoms of dysfunction of the masticatory 
system. This confirms the validity of the patient's examina-
tion and assessment as a whole to solve the local problem. 
The authors recognize the need for further research in this 
area on a larger study group, which will allow drawing 
binding conclusions. 
 
 
V. CONCLUSION 
 
 Patients with hyperthyroidism show symptoms 
of hypovobility of SSŻ. In the case of patients 
with hypothyroidism, however, hypomobility of 
SSŻ is more common. In addition, in the case of 
hyperthyroidism, the most frequent occurrence of 
polyarticular laxity was noted. 
 Patients with Hashimoto's disease have an in-
creased sensitivity to fasciocomial pain and the 
most often diagnosed in their case are TMJ pain 
syndromes. 
 Tension headaches and tinnitus co-occur with 
TMJ disorders in thyroid diseases. 
 However, there were no differences between 
the occurrence of the above features in individual 
dysfunctions of the thyroid gland. 
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